Sign in

CIK 0001446847

  • Accelerated filer
  • Smaller reporting company

IRONWOOD PHARMACEUTICALS INC

Sign in to watch
Ticker
IRWD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
043404176
Phone
+1 617-621-7722
Business address
100 SUMMER STREET, SUITE 2300, BOSTON, MA, 02110
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-11-18 Davis Andrew SVP, Chief Business Officer Sale −5,360 $4.08 $22K 284,685
2024-05-20 Davis Andrew SVP, Chief Business Officer Sale −22,725 $6.45 $147K 288,031
2024-03-08 Davis Andrew SVP, Chief Business Officer Option exercise +37,120 310,756
2024-03-08 Davis Andrew SVP, Chief Business Officer Option exercise · Performance-based Restricted Stock Unit −37,120 0
2024-02-12 Davis Andrew SVP, Chief Business Officer Sale −9,846 $15.24 $150K 208,324
2024-02-12 Davis Andrew SVP, Chief Business Officer Grant or award +65,312 273,636
2024-02-12 Davis Andrew SVP, Chief Business Officer Grant or award · Performance-based Restricted Stock Unit +32,656 32,656
2023-11-20 Davis Andrew SVP, Chief Business Officer Sale −3,287 $9.69 $32K 217,374
2023-05-22 Davis Andrew SVP, Chief Business Officer Sale −6,305 $10.12 $64K 219,327
2023-03-08 Davis Andrew SVP, Chief Business Officer Grant or award +74,236 225,632
2023-03-08 Davis Andrew SVP, Chief Business Officer Grant or award · Performance-based Restricted Stock Units +37,118 37,118
2023-02-28 Davis Andrew SVP, Chief Business Officer Sale −1,822 $11.31 $21K 151,396
2023-02-27 Davis Andrew SVP, Chief Business Officer Sale −1,751 $11.41 $20K 153,218
2022-11-21 Davis Andrew SVP, Chief Business Officer Sale −3,335 $11.56 $39K 154,213

Page 1 of 1 · 14 trades